chairman needs to go

It is my firm belief that BYR has no clear future under the leadership of Ron Gajewski.

The market has delivered its verdict of zero confidence. I argue that if BYR is to survive and flourish it will need to do that with Ron removed from the company.

Given Ron?s shady history as chairman in Citrofresh International (See Sydney Morning Herald extract below) and now that he has duped existing investors in Burey Gold he needs to be removed forthwith.

It is hard to imagine a future for the company given that he has clearly mislead BYR shareholders by failing to release drilling results in a timely manner, once again failing to disclose vital information, as happened previously with Citrofresh.

Can you imagine trying to attract new shareholders now, other than day traders hoping to score a bounce???

If the figures for Mansounia are indeed robust then surely BYR has a value that is way above the current share price. In the interest of every shareholder, I urge that the current board, and PRU as the major shareholder, bring about a no confidence motion in the current chairman and have him removed allowing BYR to regain some credibility as an exploration company.

Toastman


Citrofresh sued for HIV claims
August 26, 2006
AdvertisementAdvertisement
THE corporate regulator has attacked Citrofresh International's claim that its citrus-based disinfectant spray could act as an "invisible condom" to prevent the spread of HIV and other diseases.
The Australian Securities and Investments Commission is seeking a civil penalty of $200,000 and to disqualify the Geelong company's managing director, Ravi Narain, from managing corporations. In a suit being heard in the Federal Court in Melbourne, it accuses Citrofresh of engaging in "misleading or deceptive conduct" in an announcement to the ASX last September.
But it is understood ASIC has decided not to go after two directors who sold large parcels of shares on the same day Citrofresh released the announcement, which sent shares soaring from 22c to a peak of 70c in one day. ASIC is apparently not confident of ensuring a prosecution.
Former independent director Mathew Walker and former chairman Ron Gajewski sold out at 57.7c and 56.2c respectively - the highest price reached in four years.
The next day, the ASX asked Citrofresh whether its product was a vaccine or a cure for AIDS. When the company admitted its disinfectant spray was neither, the shares dived.
Citrofresh shares have never come close to the 50c level since.
They rose 2c to 24c on Friday but the company did not inform the market of the impending ASIC case before the close of trading.
Mr Walker picked up $577,000 through his share sale, while a company associated with Mr Gajewski grossed $281,000. Both have since resigned from Citrofresh's board. The company gave no explanation in either case.
ASIC alleges the announcement in question failed to disclose the product was a disinfectant, not a vaccine, and that the company's representations were either false or there were no reasonable grounds for making them.
In October Mr Narain told the Herald he thought the share price had spiked because day traders had misread the announcement. "It's not my fault," he said. "I don't retract any claims in the announcement."
At the time, Mr Walker declined to say why he had sold all of his Citrofresh shares on the day of the bullish announcement, calling it "a little bit personal". He said it was proper for directors to sell after an announcement rather than before.
"For a public company director to sell shares is not doing anything wrong," Mr Walker said.
Mr Narain did not return a phone call from the Herald on Friday.
Jamie Freed